| Recent advances in curcumin nanoformulation for cancer therapy WH Lee, CY Loo, PM Young, D Traini, RS Mason, R Rohanizadeh Expert opinion on drug delivery 11 (8), 1183-1201, 2014 | 129 | 2014 |
| Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems PM Young, A Sung, D Traini, P Kwok, H Chiou, HK Chan Pharmaceutical research 24 (5), 963-970, 2007 | 111 | 2007 |
| The influence of dose on the performance of dry powder inhalation systems PM Young, S Edge, D Traini, MD Jones, R Price, D El-Sabawi, C Urry, ... International Journal of Pharmaceutics 296 (1-2), 26-33, 2005 | 110 | 2005 |
| The influence of lactose pseudopolymorphic form on salbutamol sulfate–lactose interactions in DPI formulations D Traini, PM Young, F Thielmann, M Acharya Drug development and industrial pharmacy 34 (9), 992-1001, 2008 | 100 | 2008 |
| Co-spray-dried mannitol–ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease H Adi, PM Young, HK Chan, H Agus, D Traini European Journal of Pharmaceutical Sciences 40 (3), 239-247, 2010 | 88 | 2010 |
| Micro-particle corrugation, adhesion and inhalation aerosol efficiency S Adi, H Adi, P Tang, D Traini, H Chan, PM Young European Journal of Pharmaceutical Sciences 35 (1-2), 12-18, 2008 | 88 | 2008 |
| The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects PGA Rogueda, D Traini Expert opinion on drug delivery 4 (6), 595-606, 2007 | 88 | 2007 |
| Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model M Haghi, PM Young, D Traini, R Jaiswal, J Gong, M Bebawy Drug development and industrial pharmacy 36 (10), 1207-1214, 2010 | 87 | 2010 |
| Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation H Adi, I Larson, H Chiou, P Young, D Traini, P Stewart Pharmaceutical research 23 (11), 2556-2565, 2006 | 87 | 2006 |
| Preparation and characterisation of controlled release co-spray dried drug–polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for … RO Salama, D Traini, HK Chan, PM Young European Journal of Pharmaceutics and Biopharmaceutics 70 (1), 145-152, 2008 | 86 | 2008 |
| Delivery of antibiotics to the respiratory tract: an update D Traini, PM Young Expert opinion on drug delivery 6 (9), 897-905, 2009 | 74 | 2009 |
| The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations H Adi, D Traini, HK Chan, PM Young Journal of pharmaceutical sciences 97 (7), 2780-2788, 2008 | 72 | 2008 |
| A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics JGY Chan, HK Chan, CA Prestidge, JA Denman, PM Young, D Traini European Journal of Pharmaceutics and Biopharmaceutics 83 (2), 285-292, 2013 | 70 | 2013 |
| Combination of silver nanoparticles and curcumin nanoparticles for enhanced anti-biofilm activities CY Loo, R Rohanizadeh, PM Young, D Traini, R Cavaliere, ... Journal of agricultural and food chemistry 64 (12), 2513-2522, 2015 | 69 | 2015 |
| Cospray dried antibiotics for dry powder lung delivery H Adi, PM Young, HK Chan, P Stewart, H Agus, D Traini Journal of pharmaceutical sciences 97 (8), 3356-3366, 2008 | 66 | 2008 |
| The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance PM Young, H Chan, H Chiou, S Edge, THS Tee, D Traini Journal of pharmaceutical sciences 96 (5), 1331-1341, 2007 | 65 | 2007 |
| Surface energy and interparticle force correlation in model pMDI formulations D Traini, P Rogueda, P Young, R Price Pharmaceutical research 22 (5), 816-825, 2005 | 61 | 2005 |
| Nano-and micro-based inhaled drug delivery systems for targeting alveolar macrophages WH Lee, CY Loo, D Traini, PM Young Expert opinion on drug delivery 12 (6), 1009-1026, 2015 | 60 | 2015 |
| Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges WH Lee, CY Loo, D Traini, PM Young asian journal of pharmaceutical sciences 10 (6), 481-489, 2015 | 58 | 2015 |
| The use of organic vapor sorption to determine low levels of amorphous content in processed pharmaceutical powders PM Young, H Chiou, T Tee, D Traini, HK Chan, F Thielmann, D Burnett Drug development and industrial pharmacy 33 (1), 91-97, 2007 | 55 | 2007 |
Paul M YoungUniversity of SydneyVerified email at sydney.edu.au